Evidence map›Paper›PMID 35962412›Full record

ArticleBMC research notes2022

Utilization of FMOC-3F-PHE hydrogel for encapsulation of Zanthoxylum armatum and Cinnamomum camphora oil for enhancing their antibacterial activity.

Nasla Shakya, S Budha Chettri, Susan Joshi, Annada Rajbhandary

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nasla ShakyaResearch Institute for Bioscience and Biotechnology (RIBB), Kathmandu, Nepal.
S Budha ChettriTri-Chandra Multiple Campus, Durbar Marga, Kathmandu, Nepal.
Susan JoshiTri-Chandra Multiple Campus, Durbar Marga, Kathmandu, Nepal.
Annada RajbhandaryResearch Institute for Bioscience and Biotechnology (RIBB), Kathmandu, Nepal. annada_raj@hotmail.com.
Research Institute for Bioscience and Biotechnology · NP

Funding

The World Academy of Sciences 17-492 RG/CHE/AS_G-FR3240297726
6 · The paper itself

Abstract

objectiveWhile essential oils have many applications in medicine, not many studies have been done in the past to address issues of active targeting, enhancing bioavailability and reducing toxicity at higher concentrations. Herein, we used Fmoc-3F-Phe amino acid hydrogels to address such issues by encapsulating essential oils, Zanthoxylum armatum and Cinnamomum camphora, in its system and allowing sustained-release of these oils onto bacterial assays of E. coli ATCC 25922, P. hauseri NBRC 3851, M. luteus KACC 13377, and B. subtilis ATCC 66333 for probing enhanced antibacterial properties of the oils by prolonging its efficacy through controlled-release mechanism.

resultsWe found that while Zanthoxylum oil showed no particular difference in enhancing the antibacterial property against the three fast growing bacteria, however profound variation was observed against slow growing bacteria B. subtilis. The hydrogel encapsulated oil was able to retain its antibacterial property for a longer time while directly applied oil could not for this bacteria. Even for highly volatile camphor oil, the oil itself failed to show any antibacterial property with direct use, however the hydrogel encapsulated oil was able to show excellent antibacterial property for B. subtilis and M. luteus through prohibition of sublimation via encapsulation.

Indexed as

Cinnamomum camphoraOils, VolatileZanthoxylumAnti-Bacterial AgentsEscherichia coliHydrogelsAnti-Bacterial AgentsHydrogelsOils, VolatileAntibacterialCinnamomum camphoraEssential oilFmoc-3F-Phe amino acidHydrogelSustained-releaseZanthoxylum armatum

Identifiers

PMID35962412
PMCPMC9373397
OpenAlexW4291145329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.